Literature DB >> 20880509

Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes.

Marcelo R Vargas1, Jeffrey A Johnson.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal disorder characterized by the progressive loss of motor neurons. Although the molecular mechanism underlying motor neuron degeneration remains unknown; non-neuronal cells (including astrocytes) shape motor neuron survival in ALS. Astrocytes closely interact with neurons to provide an optimized environment for neuronal function and respond to all forms of injury in a typical manner known as reactive astrogliosis. A strong reactive astrogliosis surrounds degenerating motor neurons in ALS patients and ALS-animal models. Although reactive astrogliosis in ALS is probably both primary and secondary to motor neuron degeneration; astrocytes are not passive observers and they can influence motor neuron fate. Due to the important functions that astrocytes perform in the central nervous system; it is of key importance to understand how these functions are altered when astrocytes become reactive in ALS. Here; we review the current evidences supporting a potential toxic role of astrocytes and their viability as therapeutic targets to alter motor neuron degeneration in ALS.
Copyright © 2010 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20880509      PMCID: PMC2967019          DOI: 10.1016/j.nurt.2010.05.012

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  149 in total

Review 1.  The Nrf2-ARE cytoprotective pathway in astrocytes.

Authors:  Marcelo R Vargas; Jeffrey A Johnson
Journal:  Expert Rev Mol Med       Date:  2009-06-03       Impact factor: 5.600

Review 2.  Astrocytes and the regulation of cerebral blood flow.

Authors:  Raymond C Koehler; Richard J Roman; David R Harder
Journal:  Trends Neurosci       Date:  2009-01-21       Impact factor: 13.837

Review 3.  Tripartite synapses: astrocytes process and control synaptic information.

Authors:  Gertrudis Perea; Marta Navarrete; Alfonso Araque
Journal:  Trends Neurosci       Date:  2009-07-15       Impact factor: 13.837

4.  The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis.

Authors:  Lijun Wang; Kamal Sharma; Gabriella Grisotti; Raymond P Roos
Journal:  Neurobiol Dis       Date:  2009-05-12       Impact factor: 5.996

5.  Uniquely hominid features of adult human astrocytes.

Authors:  Nancy Ann Oberheim; Takahiro Takano; Xiaoning Han; Wei He; Jane H C Lin; Fushun Wang; Qiwu Xu; Jeffrey D Wyatt; Webster Pilcher; Jeffrey G Ojemann; Bruce R Ransom; Steven A Goldman; Maiken Nedergaard
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

6.  Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro.

Authors:  Jan Lewerenz; Philipp Albrecht; Mai-Ly Tran Tien; Nadine Henke; Saravanan Karumbayaram; Harley I Kornblum; Martina Wiedau-Pazos; Dave Schubert; Pamela Maher; Axel Methner
Journal:  J Neurochem       Date:  2009-08-18       Impact factor: 5.372

7.  Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

Authors:  Kevin D Foust; Emily Nurre; Chrystal L Montgomery; Anna Hernandez; Curtis M Chan; Brian K Kaspar
Journal:  Nat Biotechnol       Date:  2008-12-21       Impact factor: 54.908

8.  Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice.

Authors:  Sungju Park; Hyoung-Tae Kim; Seokkwan Yun; Il-Sun Kim; Jiyoon Lee; Il-Shin Lee; Kook In Park
Journal:  Exp Mol Med       Date:  2009-07-31       Impact factor: 8.718

9.  Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.

Authors:  Arie Neymotin; Susanne Petri; Noel Y Calingasan; Elizabeth Wille; Peter Schafer; Charles Stewart; Kenneth Hensley; M Flint Beal; Mahmoud Kiaei
Journal:  Exp Neurol       Date:  2009-09-04       Impact factor: 5.330

Review 10.  Signaling by death receptors in the nervous system.

Authors:  Georg Haase; Brigitte Pettmann; Cédric Raoul; Christopher E Henderson
Journal:  Curr Opin Neurobiol       Date:  2008-06       Impact factor: 6.627

View more
  50 in total

1.  Changes in Protein Expression and Lysine Acetylation Induced by Decreased Glutathione Levels in Astrocytes.

Authors:  Mariana Pehar; Lauren E Ball; Deep R Sharma; Benjamin A Harlan; Susana Comte-Walters; Benjamin A Neely; Marcelo R Vargas
Journal:  Mol Cell Proteomics       Date:  2015-10-20       Impact factor: 5.911

2.  Electrophilic nitro-fatty acids prevent astrocyte-mediated toxicity to motor neurons in a cell model of familial amyotrophic lateral sclerosis via nuclear factor erythroid 2-related factor activation.

Authors:  Pablo Diaz-Amarilla; Ernesto Miquel; Andrés Trostchansky; Emiliano Trias; Ana M Ferreira; Bruce A Freeman; Patricia Cassina; Luis Barbeito; Marcelo R Vargas; Homero Rubbo
Journal:  Free Radic Biol Med       Date:  2016-03-22       Impact factor: 7.376

3.  DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.

Authors:  Pilar Larrodé; Ana Cristina Calvo; Laura Moreno-Martínez; Miriam de la Torre; Leticia Moreno-García; Nora Molina; Tomás Castiella; Cristina Iñiguez; Luis Fernando Pascual; Francisco Javier Miana Mena; Pilar Zaragoza; Santiago Ramón Y Cajal; Rosario Osta
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

4.  Aberrant neuregulin 1 signaling in amyotrophic lateral sclerosis.

Authors:  Fei Song; Pohung Chiang; Jiajing Wang; John Ravits; Jeffrey A Loeb
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

5.  Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo.

Authors:  Sophia T Papadeas; Sarah E Kraig; Colin O'Banion; Angelo C Lepore; Nicholas J Maragakis
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

Review 6.  Astrocytes and synaptic plasticity in health and disease.

Authors:  A Singh; Wickliffe C Abraham
Journal:  Exp Brain Res       Date:  2017-03-15       Impact factor: 1.972

7.  Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.

Authors:  Lorelei Stoica; Sophia H Todeasa; Gabriela Toro Cabrera; Johnny S Salameh; Mai K ElMallah; Christian Mueller; Robert H Brown; Miguel Sena-Esteves
Journal:  Ann Neurol       Date:  2016-03-11       Impact factor: 10.422

8.  Expression of Wnt5a and its receptor Fzd2 is changed in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice.

Authors:  Xiaojin Li; Yingjun Guan; Yanchun Chen; Caixia Zhang; Caixing Shi; Fenghua Zhou; Li Yu; Juan Juan; Xin Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

Review 9.  "Targeting astrocytes in CNS injury and disease: A translational research approach".

Authors:  Angela R Filous; Jerry Silver
Journal:  Prog Neurobiol       Date:  2016-03-26       Impact factor: 11.685

10.  Perilipin 4 Protein: an Impending Target for Amyotrophic Lateral Sclerosis.

Authors:  Lei Zhu; Fan Hu; Cheng Li; Caixiang Zhang; Ruiwen Hang; Renshi Xu
Journal:  Mol Neurobiol       Date:  2020-11-26       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.